Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
VY-AADC(University of California) in Young onset Parkinson disease: NCT07267065 Clinical Landscape Report 2026
16 October 2026
NCT07267065 clinical landscape for Young onset Parkinson disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Garutadustat in Colitis, Ulcerative: NCT07265570 Clinical Landscape Report 2026
16 October 2026
NCT07265570 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Budesonide/Formoterol fumarate/Glycopyrronium Bromide in Pulmonary Disease, Chronic Obstructive: CTRI/2025/12/098671 Clinical Landscape Report 2026
16 October 2026
CTRI/2025/12/098671 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Colecalciferol in Colitis, Ulcerative: NCT07269223 Clinical Landscape Report 2026
16 October 2026
NCT07269223 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[68Ga]FAPI-46 in Fibrosis: NCT07273188 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_03_d2c7dad0d6.jpg)
9 min read
[68Ga]FAPI-46 in Fibrosis: NCT07273188 Clinical Landscape Report 2026
16 October 2026
NCT07273188 clinical landscape for Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atezolizumab in Hepatocellular Carcinoma: NCT07272265 Clinical Landscape Report 2026
16 October 2026
NCT07272265 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic adenocarcinoma metastatic: NCT07272109 Clinical Landscape Report 2026
16 October 2026
NCT07272109 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Atezolizumab in Unresectable Hepatocellular Carcinoma: NCT07276100 Clinical Landscape Report 2026
16 October 2026
NCT07276100 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Metformin Hydrochloride in Pulmonary Disease, Chronic Obstructive: NCT07275359 Clinical Landscape Report 2026
16 October 2026
NCT07275359 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
JMT-106 in Hepatocellular Carcinoma: NCT07275073 Clinical Landscape Report 2026
16 October 2026
NCT07275073 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fluticasone furoate in Pulmonary Disease, Chronic Obstructive: CTRI/2025/12/098826 Clinical Landscape Report 2026
16 October 2026
CTRI/2025/12/098826 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Albumin-Bound Paclitaxel in squamous cell carcinoma of the anus: NCT07280377 Clinical Landscape Report 2026
16 October 2026
NCT07280377 clinical landscape for squamous cell carcinoma of the anus: endpoints, sponsor, phase, geography, readouts, asset context and development white s…